The table below shows ANAVEX LIFE SCIENCES CORP.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$39.04M
-$30.81M
-$27.79M
-$24.24M
-$30.38M
-$21.29M
Capital expenditure
-
-
-
-
-
-
Investing cash flow
-
-
-
-
-
-
Dividends paid
-
-
-
-
-
-
AVXL operating cash flow (10-K history)
ANAVEX LIFE SCIENCES CORP. reported operating cash flow of -$39.04M for fiscal year 2025. That is down 26.7% from -$30.81M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$9.24M (FY 2016) to -$39.04M. Figures come from the company's audited annual reports as filed with the SEC.